Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
The Journal of Dermatological Treatment
|
August 19, 2016
Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis
Huaming Tan, Hernan Valdez, Chris E M Griffins, et al.
Acta Dermato-Venereologica
|
April 23, 2020
Evaluating the Efficacy of Crisaborole Using the Atopic Dermatitis Severity Index and Percentage of Affected Body Surface Area
Jonathan I Silverberg, Anna M Tallman, William C Ports, et al.
Scientific Reports
|
September 10, 2016
CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis
Xiaoyan Xin, Xianqin Zeng, Huajian Gu, et al.
American Journal of Clinical Oncology
|
June 7, 2007
Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment
Min Yao, Pifu Luo, Henry T Hoffman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 6, 2007
The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy-the university of iowa experience
Min Yao, Kristi Chang, Gerry F Funk, et al.
BMC Dermatology
|
May 9, 2015
Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis
Fernando Valenzuela, Kim A Papp, David Pariser, et al.
Journal of the American Academy of Dermatology
|
October 30, 2017
T-cell-mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib treatment
Kevin L Winthrop, Neil Korman, William Abramovits, et al.
Paediatric Drugs
|
March 16, 2022
Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years
Thomas A Luger, Adelaide A Hebert, Andrea L Zaenglein, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 24, 2007
Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy?
Min Yao, Henry T Hoffman, Kristi Chang, et al.
Journal of the American Academy of Dermatology
|
August 9, 2016
Effects of tofacitinib on cardiovascular risk factors and cardiovascular outcomes based on phase III and long-term extension data in patients with plaque psoriasis
Jashin J Wu, Bruce E Strober, Peter R Hansen, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
The Journal of Dermatological Treatment
|
August 19, 2016
Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis
Huaming Tan, Hernan Valdez, Chris E M Griffins, et al.
Acta Dermato-Venereologica
|
April 23, 2020
Evaluating the Efficacy of Crisaborole Using the Atopic Dermatitis Severity Index and Percentage of Affected Body Surface Area
Jonathan I Silverberg, Anna M Tallman, William C Ports, et al.
Scientific Reports
|
September 10, 2016
CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis
Xiaoyan Xin, Xianqin Zeng, Huajian Gu, et al.
American Journal of Clinical Oncology
|
June 7, 2007
Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment
Min Yao, Pifu Luo, Henry T Hoffman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 6, 2007
The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy-the university of iowa experience
Min Yao, Kristi Chang, Gerry F Funk, et al.
BMC Dermatology
|
May 9, 2015
Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis
Fernando Valenzuela, Kim A Papp, David Pariser, et al.
Journal of the American Academy of Dermatology
|
October 30, 2017
T-cell-mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib treatment
Kevin L Winthrop, Neil Korman, William Abramovits, et al.
Paediatric Drugs
|
March 16, 2022
Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years
Thomas A Luger, Adelaide A Hebert, Andrea L Zaenglein, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 24, 2007
Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy?
Min Yao, Henry T Hoffman, Kristi Chang, et al.
Journal of the American Academy of Dermatology
|
August 9, 2016
Effects of tofacitinib on cardiovascular risk factors and cardiovascular outcomes based on phase III and long-term extension data in patients with plaque psoriasis
Jashin J Wu, Bruce E Strober, Peter R Hansen, et al.
Page
of 4